Chandler Robinson Monopar Therapeutics (MNPR) insider trading activity

MNPR Quotes by TradingView

Chandler Robinson is Chief Executive Officer of Monopar Therapeutics. Currently has a direct ownership of 85,718 shares of MNPR, which is worth approximately $6.69 Million. The most recent transaction as insider was on Jan 01, 2021, when has been sold 6,724 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.7K
7.75% 3M change
45.66% 12M change
Total Value Held $6.69 Million

Chandler Robinson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
6,724 Added 24.5%
20,726 Common Stock
CR

Chandler Robinson

Chief Executive Officer
Wilmette, IL

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MNPR